WHO halts hydroxychloroquine and lopinavir/ritonavir trials due to lack of benefits

WHO discontinues hydroxychloroquine and lopinavir/ritonavir treatment arms in the Solidarity trial due to lack of beneficial results.
WHO discontinues hydroxychloroquine and lopinavir/ritonavir treatment arms in the Solidarity trial due to lack of beneficial results.